Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novo Nordisk A/S
  6. News
  7. Summary
    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
Delayed Quote. Delayed Nasdaq Copenhagen - 12/06 10:59:57 am
708.6 DKK   +0.61%
12/03European ADRs Move Sharply Lower in Friday Trading
MT
12/03Drugmakers cut prices by 62% on average to get China state insurance listing
RE
11/29Novo Nordisk A/S – Share repurchase programme
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

NOVO NORDISK : Buy rating from Goldman Sachs

10/14/2021 | 05:44am EST

In a research note published by Keyur Parekh, Goldman Sachs advises its customers to buy the stock. The target price remains set at DKK 770.


© MarketScreener with dpa-AFX Analyser 2021
All news about NOVO NORDISK A/S
12/03European ADRs Move Sharply Lower in Friday Trading
MT
12/03Drugmakers cut prices by 62% on average to get China state insurance listing
RE
11/29Novo Nordisk A/S – Share repurchase programme
AQ
11/29NOVO NORDISK : Deutsche Bank reaffirms its Buy rating
MD
11/26Novo Nordisk Secures Canadian Approval for Weight Loss Drug Wegovy
MT
11/26NOVO NORDISK : Gets a Neutral rating from UBS
MD
11/26NOVO NORDISK : JP Morgan gives a Buy rating
MD
11/26NOVO NORDISK : Bernstein remains its Buy rating
MD
11/26MASIH YAZDI : EUROPEAN MIDDAY BRIEFING - Stocks, Oil Drop on -2-
DJ
11/26Novo Nordisk says lower insulin prices in China dent 2022 outlook
RE
More news
Analyst Recommendations on NOVO NORDISK A/S
More recommendations
Financials
Sales 2021 139 B 21 164 M 21 164 M
Net income 2021 47 451 M 7 200 M 7 200 M
Net cash 2021 4 729 M 718 M 718 M
P/E ratio 2021 34,3x
Yield 2021 1,43%
Capitalization 1 616 B 245 B 245 B
EV / Sales 2021 11,6x
EV / Sales 2022 10,4x
Nbr of Employees 46 982
Free-Float 69,8%
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO B | DK0060534915 | MarketScreener
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 26
Last Close Price 708,60 DKK
Average target price 681,04 DKK
Spread / Average Target -3,89%
EPS Revisions
Managers and Directors
Lars Fruergaard Jørgensen President & Chief Executive Officer
Karsten Munk Knudsen Chief Financial Officer & Executive Vice President
Helge Lund Chairman
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Henrik Ehlers Wulff Executive VP & Head-Information Technology
Sector and Competitors
1st jan.Capi. (M$)
NOVO NORDISK A/S64.51%244 010
JOHNSON & JOHNSON1.27%419 583
ROCHE HOLDING AG17.62%341 364
PFIZER, INC.44.09%304 610
ELI LILLY AND COMPANY47.55%222 641
ABBVIE INC.8.18%210 113